Cash position strengthened: In February 2025, Keros received a $200.0 million upfront payment pursuant to the exclusive ...

Corundum Systems Biology, an investment firm supporting early-stage companies developing biomedical solutions, hired operating partner Henry Haiser, PhD from Takeda and Rotem Gura-Sadovsky, PhD as ...

Reports Q4 revenue $3.04M vs. $143,000 last year. “The efforts over the past year by the team at Keros have positioned us to continue to ...